Results 91 to 100 of about 184,985 (319)

Portal vein hypoplasia in dogs [PDF]

open access: yes, 2014
Portal vein hypoplasia (PVH) is a congenital disorder, in which microscopic intrahepatic shunts are present, causing blood to bypass the liver sinusoids.
De Cock, HEV   +6 more
core  

Hepatic infarction following abdominal interventional procedures. [PDF]

open access: yes, 2004
To clarify the incidence, background, and progress of hepatic infarction following interventional procedures, cases of hepatic infarction following interventional procedures at our department during the last decade were identified by reviewing the ...
Akaki, Shiro   +9 more
core   +1 more source

Refining Prognosis in Cirrhosis Patients With Ascites: Impact of Acute vs. Non‐Acute Decompensation

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
The novel classification of acute and non‐acute decompensation provides prognostic information, but the role of hospitalisation status should be reconsidered. ABSTRACT Background A more granular understanding of hepatic decompensation in cirrhosis has led to the classification of acute decompensation (AD) and non‐acute decompensation (NAD).
Lucie Simonis   +19 more
wiley   +1 more source

Congenital intrahepatic portosystemic shunt diagnosed during intrauterine life

open access: yesRevista Paulista de Pediatria
Objective: To report a patient with prenatal diagnosis of portosystemic shunt; a rare condition in humans. Case description: 17-Day-old female infant admitted for investigation of suspected diagnosis of portosystemic shunt, presumed in obstetric ...
Camila Vieira Bellettini   +6 more
doaj   +1 more source

Hypoxia due to intrapulmonary vascular dilatation in a toddler with a congenital portacaval shunt: case report

open access: yesBMC Pulmonary Medicine, 2019
Background The term hepatopulmonary syndrome typically applies to cyanosis that results from “intrapulmonary vascular dilatation” due to advanced liver disease. Similar findings may result from a congenital portosystemic shunt without liver disease.
Mohammed T. Alsamri   +4 more
doaj   +1 more source

Portal Revascularization in the Setting of Cavernous Transformation Through a Paracholedocal Vein: A Case Report [PDF]

open access: yes, 2010
Diffuse thrombosis of the entire portal system (PVT) and cavernomatous transformation of the portal vein (CTPV) represents a demanding challenge in liver transplantation.
Bueno, A. (Álvaro)   +6 more
core   +1 more source

Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPS

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
In patients with cirrhosis undergoing TIPS, frailty—measured by the Liver Frailty Index—improved in those with poor baseline status; therefore, high frailty should not be seen as a contraindication to elective TIPS. Additionally, LFI assessment before TIPS enables identification of patients with excellent survival prognosis.
Martin Andreas Kabelitz   +16 more
wiley   +1 more source

Endoscopic Management of Gastric Variceal Bleeding with Cyanoacrylate Glue Injection: Safety and Efficacy in a Canadian Population

open access: yesCanadian Journal of Gastroenterology, 2010
BACKGROUND: Gastric variceal bleeding (GVB) is a major cause of morbidity and mortality among patients with portal hypertension. Endoscopic band ligation and standard sclerotherapy have been used but have significant limitations.
Jaber Al-Ali   +5 more
doaj   +1 more source

Anesthesia for cystotomy in a dog with pancreatitis and a portosystemic shunt [PDF]

open access: yes, 2010
A 21-month-old Cocker spaniel with a portosystemic shunt, a moderate thrombocytopenia and a history of pancreatitis, was anesthetized for a cystotomy to remove bladder polyps and stones.
Brearley, JC   +3 more
core   +1 more source

Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
Features of clinically significant portal hypertension (CSPH) in patients with autoimmune hepatitis indicate a substantial risk for decompensation and impaired transplant‐free survival. Non‐invasive risk prediction based on liver stiffness measurement ≥ 15 kPa and/or thrombocytopenia (< 150 G/L) serves as a valuable surrogate to identify patients at ...
Lukas Burghart   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy